Katherine K S Rieth1, Steven R Gill2, Abberly A Lott-Limbach3, Mark A Merkley1, Nathalia Botero4, Paul D Allen1, Matthew C Miller1. 1. Department of Otolaryngology, University of Rochester Medical Center, Rochester, New York. 2. Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York. 3. Department of Pathology, University of Rochester Medical Center, Rochester, New York. 4. University of Rochester, Rochester, New York.
Abstract
IMPORTANCE: The pathogenesis of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma is currently an important topic of elucidation. The presence of latent HPV infection in tonsil tissue of healthy adults may provide an explanation for a component of this process and contribute to the understanding of HPV-associated squamous cell carcinoma oncogenesis of the oropharynx. OBJECTIVE: To determine the prevalence of oropharyngeal HPV and to determine the spatial relationship between the virus and crypt biofilm in tonsil tissue. DESIGN, SETTING, AND PARTICIPANTS: A retrospective, cross-sectional study was carried out using samples obtained from tonsils that were archived at a university hospital following elective nononcologic tonsillectomy from 2012 to 2015. Samples consisted of formalin-fixed paraffin embedded samples of tumor-free tonsil tissue from 102 adults between the ages of 20 and 39 years. EXPOSURES: Human papillomavirus status was assessed by polymerase chain reaction, and high-risk subtypes 16 and 18 were assessed with quantitative polymerase chain reaction assay. Samples that demonstrated presence of HPV were then analyzed by in situ hybridization to localize the viral capsid protein. These samples were then stained with concanavalin A to establish biofilm presence and morphology. These samples were also stained with diamidino-phenylindole (DAPI) to visualize location of the virus in relation to cell nuclei. These data were then assembled for aggregate analysis to colocalize HPV in the biofilm of the tonsillar crypts. MAIN OUTCOMES AND MEASURES: Outcome measurements were determined prior to data collection and include prevalence of high-risk HPV types 16 and 18 in tonsil tissue of otherwise healthy adults, as well as demonstration with immunohistochemistry of HPV in tonsillar crypt biofilm. RESULTS: In 102 otherwise healthy adults (55 [53.9%] female; age range, 20-39 years), the overall prevalence of HPV in tonsils was 4.9% (n = 5); and high-risk type 16 or 18, 3.9% (n = 4). In this sample population, in situ hybridization colocalized HPV virus to the biofilm of the tonsillar crypts. CONCLUSIONS AND RELEVANCE: Biofilm is present in the tonsillar crypts in a considerable proportion of tonsil tissues and may be reproducibly identified. Human papillomavirus is demonstrated to colocalize to the crypt biofilm. This has important implications with respect to the determination of HPV prevalence rates in the oropharynx. It may also play a role in the pathogenesis of HPV-related oropharyngeal carcinoma.
IMPORTANCE: The pathogenesis of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma is currently an important topic of elucidation. The presence of latent HPV infection in tonsil tissue of healthy adults may provide an explanation for a component of this process and contribute to the understanding of HPV-associated squamous cell carcinoma oncogenesis of the oropharynx. OBJECTIVE: To determine the prevalence of oropharyngeal HPV and to determine the spatial relationship between the virus and crypt biofilm in tonsil tissue. DESIGN, SETTING, AND PARTICIPANTS: A retrospective, cross-sectional study was carried out using samples obtained from tonsils that were archived at a university hospital following elective nononcologic tonsillectomy from 2012 to 2015. Samples consisted of formalin-fixed paraffin embedded samples of tumor-free tonsil tissue from 102 adults between the ages of 20 and 39 years. EXPOSURES: Human papillomavirus status was assessed by polymerase chain reaction, and high-risk subtypes 16 and 18 were assessed with quantitative polymerase chain reaction assay. Samples that demonstrated presence of HPV were then analyzed by in situ hybridization to localize the viral capsid protein. These samples were then stained with concanavalin A to establish biofilm presence and morphology. These samples were also stained with diamidino-phenylindole (DAPI) to visualize location of the virus in relation to cell nuclei. These data were then assembled for aggregate analysis to colocalize HPV in the biofilm of the tonsillar crypts. MAIN OUTCOMES AND MEASURES: Outcome measurements were determined prior to data collection and include prevalence of high-risk HPV types 16 and 18 in tonsil tissue of otherwise healthy adults, as well as demonstration with immunohistochemistry of HPV in tonsillar crypt biofilm. RESULTS: In 102 otherwise healthy adults (55 [53.9%] female; age range, 20-39 years), the overall prevalence of HPV in tonsils was 4.9% (n = 5); and high-risk type 16 or 18, 3.9% (n = 4). In this sample population, in situ hybridization colocalized HPV virus to the biofilm of the tonsillar crypts. CONCLUSIONS AND RELEVANCE: Biofilm is present in the tonsillar crypts in a considerable proportion of tonsil tissues and may be reproducibly identified. Human papillomavirus is demonstrated to colocalize to the crypt biofilm. This has important implications with respect to the determination of HPV prevalence rates in the oropharynx. It may also play a role in the pathogenesis of HPV-related oropharyngeal carcinoma.
Authors: Rebecca D Chernock; Brian Nussenbaum; Wade L Thorstad; Yuling Luo; Xiao-Jun Ma; Samir K El-Mofty; James S Lewis Journal: Head Neck Pathol Date: 2013-10-23
Authors: Romain E Kania; Gerda E M Lamers; Marcel J Vonk; Patrice Tran Ba Huy; Pieter S Hiemstra; Guido V Bloemberg; Jan J Grote Journal: Arch Otolaryngol Head Neck Surg Date: 2007-02
Authors: Romain E Kania; Gerda E M Lamers; Marcel J Vonk; Esmee Dorpmans; Joyce Struik; Patrice Tran Ba Huy; Pieter Hiemstra; Guido V Bloemberg; Jan J Grote Journal: Laryngoscope Date: 2008-01 Impact factor: 3.325
Authors: C E Depuydt; G A V Boulet; C A J Horvath; I H Benoy; A J Vereecken; J J Bogers Journal: J Cell Mol Med Date: 2007 Jul-Aug Impact factor: 5.310
Authors: Anna Holm; Alexandra Schindele; Annika Allard; Irene Eriksson; Karl Sandström; Göran Laurell; Karin Nylander; Katarina Olofsson Journal: Laryngoscope Investig Otolaryngol Date: 2019-04-12
Authors: Ahmet Volkan Sünter; Bahtiyar Hamit; Özgür Yiğit; Ela Araz Server; Elif Ömeroğlu Kara; Aysel Karataş; Mert Ahmet Kuşkucu; Yağmur Eylül Doğantürk; Kenan Midilli Journal: Turk Arch Otorhinolaryngol Date: 2019-09-01